Millennium Pharmacon (Indonesia) Analysis
| SDPC Stock | IDR 135.00 1.00 0.75% |
Millennium Pharmacon International is overvalued with Real Value of 120.54 and Hype Value of 134.0. The main objective of Millennium Pharmacon stock analysis is to determine its intrinsic value, which is an estimate of what Millennium Pharmacon International is worth, separate from its market price. There are two main types of Millennium Pharmacon's stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect Millennium Pharmacon's performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of Millennium Pharmacon's stock to identify patterns and trends that may indicate its future price movements.
The Millennium Pharmacon stock is traded in Indonesia on Jakarta Exchange, with the market opening at 09:00:00 and closing at 15:50:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in Indonesia.
Millennium |
Millennium Stock Analysis Notes
About 88.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 1.16. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Millennium Pharmacon recorded earning per share (EPS) of 19.19. The entity last dividend was issued on the 20th of May 2022. PT Millennium Pharmacon International Tbk distributes and trades in prescription medicine, non-prescription medicine, food supplements, and medical devices. PT Millennium Pharmacon International Tbk is a subsidiary of Pharmaniaga International Corporation Sdn. Millennium Pharmacon operates under Medical Distribution classification in Indonesia and is traded on Jakarta Stock Exchange. It employs 1092 people. To find out more about Millennium Pharmacon International contact the company at 62 21 270 85961 or learn more at https://www.mpi-indonesia.co.id.Millennium Pharmacon Investment Alerts
| Millennium Pharmacon had very high historical volatility over the last 90 days | |
| Millennium Pharmacon has high financial leverage indicating that it may have difficulties to generate enough cash to satisfy its financial obligations | |
| Millennium Pharmacon International has accumulated about 43.62 B in cash with (18.18 B) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 34.24. | |
| Roughly 88.0% of the company outstanding shares are owned by corporate insiders |
Millennium Market Capitalization
The company currently falls under 'Mega-Cap' category with a current market capitalization of 440.8 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Millennium Pharmacon's market, we take the total number of its shares issued and multiply it by Millennium Pharmacon's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Millennium Profitablity
Millennium Pharmacon's profitability indicators refer to fundamental financial ratios that showcase Millennium Pharmacon's ability to generate income relative to its revenue or operating costs. If, let's say, Millennium Pharmacon is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Millennium Pharmacon's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Millennium Pharmacon's profitability requires more research than a typical breakdown of Millennium Pharmacon's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of 0.01 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.02 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.02. Technical Drivers
As of the 2nd of December, Millennium Pharmacon secures the Downside Deviation of 3.72, mean deviation of 2.13, and Risk Adjusted Performance of 0.0214. In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Millennium Pharmacon, as well as the relationship between them.Millennium Pharmacon Price Movement Analysis
The output start index for this execution was thirty-five with a total number of output elements of twenty-six. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Millennium Pharmacon middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Millennium Pharmacon. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Millennium Pharmacon Outstanding Bonds
Millennium Pharmacon issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Millennium Pharmacon uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Millennium bonds can be classified according to their maturity, which is the date when Millennium Pharmacon International has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| BNP Paribas FRN Corp BondUSF1R15XK367 | View | |
| AerCap Global Aviation Corp BondUS00773HAA59 | View |
Millennium Pharmacon Predictive Daily Indicators
Millennium Pharmacon intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Millennium Pharmacon stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
| Accumulation Distribution | 155212.0 | |||
| Daily Balance Of Power | 0.0667 | |||
| Rate Of Daily Change | 1.01 | |||
| Day Median Price | 131.5 | |||
| Day Typical Price | 132.67 | |||
| Price Action Indicator | 4.0 | |||
| Period Momentum Indicator | 1.0 |
Millennium Pharmacon Forecast Models
Millennium Pharmacon's time-series forecasting models are one of many Millennium Pharmacon's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Millennium Pharmacon's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Millennium Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Millennium Pharmacon prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Millennium shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Millennium Pharmacon. By using and applying Millennium Stock analysis, traders can create a robust methodology for identifying Millennium entry and exit points for their positions.
PT Millennium Pharmacon International Tbk distributes and trades in prescription medicine, non-prescription medicine, food supplements, and medical devices. PT Millennium Pharmacon International Tbk is a subsidiary of Pharmaniaga International Corporation Sdn. Millennium Pharmacon operates under Medical Distribution classification in Indonesia and is traded on Jakarta Stock Exchange. It employs 1092 people.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Millennium Pharmacon to your portfolios without increasing risk or reducing expected return.Did you try this?
Run AI Portfolio Architect Now
AI Portfolio ArchitectUse AI to generate optimal portfolios and find profitable investment opportunities |
| All Next | Launch Module |
Other Information on Investing in Millennium Stock
Millennium Pharmacon financial ratios help investors to determine whether Millennium Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Millennium with respect to the benefits of owning Millennium Pharmacon security.